Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects

NCT: NCT07094100 · RECRUITING

NCT IDNCT07094100
StatusRECRUITING
Start Date2026-04-20
Completion2028-12

Brief Summary

The joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.

Frequently Asked Questions

What is Tissue Engineered Cartilage to Repairing Articular Cartilage Defects?

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects is a clinical trial registered under NCT07094100. Current status: RECRUITING.

What is the status of NCT07094100?

The current status of NCT07094100 (Tissue Engineered Cartilage to Repairing Articular Cartilage Defects) is: RECRUITING.

When did Tissue Engineered Cartilage to Repairing Articular Cartilage Defects start?

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects started on 2026-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑